frequently referred to as HER2 (human epidermal growth factor receptor 2) or CD340 (cluster of differentiation 340). HER2 is a member of the human epidermal
chemically - induced lung cancer. FHIT also acts as a tumor suppressor of HER2/neu driven breast cancer. FHIT has been shown to interact with UBE2I. GRCh38:
doses of herceptin, selective ADAM10 inhibitors decrease proliferation in HER2 over-expressing cell lines while inhibitors, that do not inhibit ADAM10,
tumor suppressing protein. Erbin has been shown to interact with: Dystonin HER2/neu ITGB4 Mothers against decapentaplegic homolog 3 PKP4 and KSR1 GRCh38:
HOTAIR-mediated overexpression of the HER2 oncogene through sequestration of miR-331-3p, which is a negative regulator of HER2 expression. In cells, especially